Soligenix
SNGX
#10262
Rank
ยฃ9.96 M
Marketcap
ยฃ0.99
Share price
-3.62%
Change (1 day)
-56.29%
Change (1 year)

Earnings for Soligenix (SNGX)

Earnings in 2025 (TTM): -ยฃ9.46 Million

According to Soligenix's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -ยฃ6.95 Million a decrease over its 2023 earnings that were of -ยฃ5.65 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soligenix from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ9.46 Million36.21%
2024 -ยฃ6.95 Million22.96%
2023 -ยฃ5.65 Million-45.74%
2022 -ยฃ10.41 Million11.88%
2021 -ยฃ9.3 Million-32.37%
2020 -ยฃ13.75 Million83.18%
2019 -ยฃ7.51 Million11.57%
2018 -ยฃ6.73 Million19.29%
2017 -ยฃ5.64 Million33%
2016 -ยฃ4.24 Million-19.7%
2015 -ยฃ5.28 Million5.16%
2014 -ยฃ5.03 Million
2010 -ยฃ5.67 Million26.12%
2009 -ยฃ4.5 Million75.1%
2008 -ยฃ2.57 Million-45.38%
2007 -ยฃ4.7 Million-22.84%
2006 -ยฃ6.09 Million66.15%
2005 -ยฃ3.67 Million-16.65%
2004 -ยฃ4.4 Million13.28%
2003 -ยฃ3.89 Million-11.88%
2002 -ยฃ4.41 Million-59.44%
2001 -ยฃ10.86 Million378.18%
2000 -ยฃ2.28 Million-38.53%
1999 -ยฃ3.7 Million-18.43%
1998 -ยฃ4.53 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Cleveland BioLabs
CBLI
-ยฃ2.05 Million-77.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
ยฃ0.12 B-1,436.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ6.75 B-73,673.72%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
ยฃ8.80 B-95,920.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ24.05 B-262,014.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-ยฃ31.01 Million 237.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-ยฃ13.49 Million 46.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ1.31 B-14,426.25%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel